ZFIN ID: ZDB-FIG-151016-14
Jing et al., 2015 - Adenosine signaling promotes hematopoietic stem and progenitor cell emergence. The Journal of experimental medicine   212(5):649-63 Full text @ J. Exp. Med.
ADDITIONAL FIGURES
EXPRESSION / LABELING:
Genes:
Fish:
Condition:
Knockdown Reagents:
Anatomical Terms:
Stage Range: 14-19 somites to Prim-25
PHENOTYPE:
Fish:
Condition:
Knockdown Reagents:
Observed In:
Stage: Prim-25

Fig. 2 ZFIN is incorporating published figure images and captions as part of an ongoing project. Figures from some publications have not yet been curated, or are not available for display because of copyright restrictions.

Gene Expression Details
Gene Antibody Fish Conditions Stage Anatomy Assay
adora2b TU standard conditions Prim-5 blood island vasculature ISH
Prim-5 ventral wall of dorsal aorta vasculature ISH
Prim-15 intermediate cell mass of mesoderm vasculature ISH
Prim-15 ventral wall of dorsal aorta vasculature ISH
la116Tg control 14-19 somites endothelial cell RTPCR
26+ somites endothelial cell RTPCR
Prim-5 endothelial cell RTPCR
la116Tg standard conditions 26+ somites endothelial cell RTPCR
Prim-5 endothelial cell RTPCR
Prim-15 endothelial cell RTPCR
la116Tg + MO1-tnnt2a standard conditions Prim-5 endothelial cell RTPCR
EGFP la4Tg; zf169Tg control Prim-25 pronephros IFL
Prim-25 ventral wall of dorsal aorta hematopoietic multipotent progenitor cell IFL
la4Tg; zf169Tg chemical treatment: BAY 60-6583 Prim-25 pronephros IFL
Prim-25 ventral wall of dorsal aorta hematopoietic multipotent progenitor cell IFL
la4Tg; zf169Tg + MO1-adora2b standard conditions Prim-25 pronephros IFL
Prim-25 ventral wall of dorsal aorta hematopoietic multipotent progenitor cell IFL
myb TU control Prim-25 ventral wall of dorsal aorta hematopoietic multipotent progenitor cell ISH
TU standard conditions Prim-25 ventral wall of dorsal aorta hematopoietic multipotent progenitor cell ISH
TU chemical treatment: BAY 60-6583 Prim-25 ventral wall of dorsal aorta hematopoietic multipotent progenitor cell ISH
TU + MO1-adora2b standard conditions Prim-25 ventral wall of dorsal aorta hematopoietic multipotent progenitor cell ISH
TU + MO2-adora2b standard conditions Prim-25 ventral wall of dorsal aorta hematopoietic multipotent progenitor cell ISH
RFP la4Tg; zf169Tg control Prim-25 endothelial cell IFL
Prim-25 ventral wall of dorsal aorta hematopoietic multipotent progenitor cell IFL
la4Tg; zf169Tg chemical treatment: BAY 60-6583 Prim-25 endothelial cell IFL
Prim-25 ventral wall of dorsal aorta hematopoietic multipotent progenitor cell IFL
la4Tg; zf169Tg + MO1-adora2b standard conditions Prim-25 endothelial cell IFL
Prim-25 ventral wall of dorsal aorta hematopoietic multipotent progenitor cell IFL
runx1 TU control Prim-25 ventral wall of dorsal aorta hematopoietic multipotent progenitor cell ISH
TU standard conditions Prim-25 ventral wall of dorsal aorta hematopoietic multipotent progenitor cell ISH
TU chemical treatment: BAY 60-6583 Prim-25 ventral wall of dorsal aorta hematopoietic multipotent progenitor cell ISH
TU + MO1-adora2b standard conditions Prim-25 ventral wall of dorsal aorta hematopoietic multipotent progenitor cell ISH
TU + MO2-adora2b standard conditions Prim-25 ventral wall of dorsal aorta hematopoietic multipotent progenitor cell ISH
Antibody Labeling Details No data available
Phenotype Details
Fish Conditions Stage Phenotype
TU chemical treatment: BAY 60-6583 Prim-25 hematopoietic multipotent progenitor cell increased amount, abnormal
TU + MO1-adora2b standard conditions Prim-25 hematopoietic multipotent progenitor cell decreased amount, abnormal
TU + MO2-adora2b standard conditions Prim-25 hematopoietic multipotent progenitor cell decreased amount, abnormal
la4Tg; zf169Tg chemical treatment: BAY 60-6583 Prim-25 hematopoietic multipotent progenitor cell increased amount, abnormal
la4Tg; zf169Tg + MO1-adora2b standard conditions Prim-25 hematopoietic multipotent progenitor cell decreased amount, abnormal
Full text @ J. Exp. Med.